This panel addresses a topical question of immediate relevance to the current moment: has the decades-long emphasis on tailoring treatment to the genetic profile of individuals (otherwise known as precision or personalized medicine [PM]) been a distraction and an obstacle in dealing with COVID-19, and has crowded out efforts to develop the population health approaches necessary for a pandemic? Or is this a false dichotomy, and the fundamental advances made by PM research can be adapted to inform public health initiatives? Columbia University, as a center of cutting-edge PM research, as well as the only institution with a thriving program dedicated to exploring the social, ethical, legal and economic aspects of PM, is ideally positioned to begin this conversation.
For a full list of speakers and conference schedule, please visit the event webpage.
This event is open to the public, however registration is required via the event webpage. The event link will be provided to registered attendees.